Engineered T cell–agonist chimera for logic-gated STING activation and augmented cancer immunotherapy
Proceedings of the National Academy of Sciences, Volume 123, Issue 45, November 2026. SignificanceAdoptive T cell therapy (ACT) against solid tumors is largely limited by the immunosuppressive tumor microenvironment (ITME).